Find policies, billing codes, payers, states, and providers
CPT 93923: Noninvasive Arterial Diagnostic Testing
CPT code 93923 covers noninvasive arterial diagnostic procedures that evaluate blood flow and identify blockages in the upper and lower extremity arteries. These tests—such as plethysmography, segmental pressures, and Doppler waveform analysis—are essential in diagnosing peripheral arterial disease and guiding further vascular care. Nationally, such testing informs clinical decision-making for patients with diabetes, peripheral ulcers, claudication, or suspected arterial insufficiency, and supports appropriate use of advanced imaging or revascularization.
Key payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, common sites of service, and how 93923 relates to adjacent vascular procedure codes (e.g., segmental pressure studies and arterial duplex scans). The publication summarizes common coding relationships and service settings, explains typical clinical indications tied to arterial insufficiency and diabetic circulatory complications, and highlights areas where billing specificity matters (single vs. multi-level studies, upper vs. lower extremity focus).
This resource provides clinicians, coding professionals, and policy analysts a clear, national-level primer on the purpose and clinical role of CPT code 93923, and orients readers to related procedural options and common clinical scenarios prompting arterial diagnostic testing.
Customize your policy alerts
Sign up for cpt 93923 policy alerts
Get alerted when payer policies referencing 93923 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 93923 describes noninvasive arterial diagnostic procedures used to assess blood flow rates and detect arterial blockages in the upper and lower extremities. Common testing methods under this code include plethysmography, segmental blood pressure measurements, and Doppler waveform analysis.
Service Type: Noninvasive vascular arterial diagnostic testing
Typical Site of Service: Outpatient vascular laboratory, hospital outpatient department, or ambulatory imaging center
National Reimbursement Benchmarks
Nationally, Medicare averages $92.8 for CPT 93923 while BUCA’s commercial mean is $222.7, indicating BUCA pays roughly $130 more on average than Medicare for this service. Blue Cross Blue Shield sits near the high end of commercial means at $289.8, with Cigna and UnitedHealth Group closer to BUCA’s average, and Aetna a step below those peers.
Dispersion measured by the interquartile range (P75−P25) is widest for Blue Cross Blue Shield at $125 (from $220.1 to $326.5) and much narrower for Aetna at $118.9 (from $36.9 to $155.6) and Cigna at $144.1 (from $47.2 to $209.3). UnitedHealth Group’s IQR is $152.1 (from $53.9 to $206.8), while BUCA’s IQR is $123.3 (from $145.5 to $268.3); Medicare’s IQR is $111 (from $22 to $133).